Sight Diagnostics
PrivateLast Round
Series D
Aug 5, 2020
Total Funding Raised
$120.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sight Diagnostics is a health tech company that develops automated microscopy devices and AI-powered platforms for rapid, lab-grade blood testing.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Computer Vision, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sight Diagnostics Comparables
Compare Sight Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Truvian | 83% | |
| Ozelle Diagnostics | 81% | |
| Ad Astra Diagnostics | 81% |
Sight Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Aug 5, 2020 | ||||
| Series C | Feb 14, 2019 | ||||
| Series B | Aug 1, 2016 | ||||
| Series A | Apr 8, 2014 |
Key People
Founding team and executive leadership
Sight Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Alliance Capital | Series C, Series B |
| Clal Biotechnology Industries | Series C, Series A, Series D |
| Innovation Endeavors | Series A |
| GO Capital | Series C |
| Clal Industries | Series D |
| Clal Insurance Enterprises Holdings Ltd. | Series D |
| Longliv Ventures | Series C, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors grew 382% MoM, reaching 2.6K.
- Apr 21, 2026
Entire workforce of approximately 20 employees laid off.
Sight Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sight Diagnostics's valuation, stock price, and market status.
Is Sight Diagnostics a public or private company?
Sight Diagnostics is a private company.
What is the current stock price of Sight Diagnostics?
Sight Diagnostics is a private company with no public stock price. No recent secondary market data is available.
How much is Sight Diagnostics worth (valuation)?
Valuation information for Sight Diagnostics is not publicly available.
Can I buy Sight Diagnostics stock?
Sight Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sight Diagnostics's last funding round?
Sight Diagnostics's most recent funding round was Series D on August 5, 2020.
Who are the main investors in Sight Diagnostics?
Key investors in Sight Diagnostics include Longliv Ventures, Koch Disruptive Technologies.
Will Sight Diagnostics IPO soon?
No public IPO plans have been announced for Sight Diagnostics.
How can I track Sight Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sight Diagnostics's secondary market activity and sign up for updates.